JAMA Clinical Reviews podcast

Treatment of Severe Refractory Asthma

0:00
14:39
Reculer de 15 secondes
Avancer de 15 secondes

Severe refractory asthma, which affects approximately 1% to 5% of patients with asthma, is associated with increased morbidity and mortality. Author Juan Carlos Cardet, MD, MPH, of the University of South Florida joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the management of patients with severe refractory asthma, including first-line medications and biologics.

Related Content:

-----------------------------------

JAMA Editors' Summary

D'autres épisodes de "JAMA Clinical Reviews"